Natural coniferous resin lacquer in treatment of toenail onychomycosis: an observational study
- PMID: 23131104
- PMCID: PMC3666097
- DOI: 10.1111/myc.12019
Natural coniferous resin lacquer in treatment of toenail onychomycosis: an observational study
Abstract
In in vitro tests, natural coniferous resin from the Norway spruce (Picea abies) is strongly antifungal. In this observational study, we tested the clinical effectiveness of a lacquer composed of spruce resin for topical treatment of onychomycosis. Thirty-seven patients with clinical diagnosis of onychomycosis were enrolled into the study. All patients used topical resin lacquer treatment daily for 9 months. A mycological culture and potassium hydroxide (KOH) stain were done from nail samples in the beginning and in the end of the study. Treatment was considered effective, if a mycological culture was negative and there was an apparent clinical cure. At study entry, 20 patients (20/37; 54%; 95% CI: 38-70) had a positive mycological culture and/or positive KOH stain for dermatophytes. At study end, the result of 13 patients was negative (13/19; 68%; 95% CI: 48-89). In one case (1/14; 7%; 95% CI: 0-21) the mycological culture was initially negative, but it turned positive during the study period. By 14 compliant patients (14/32; 44%; 95% CI: 27-61), resin lacquer treatment was considered clinically effective: complete healing took place in three cases (9%) and partial healing in 11 cases (85%). The results indicate some evidence of clinical efficacy of the natural coniferous resin used for topical treatment of onychomycosis.
© 2012 Blackwell Verlag GmbH.
Figures
Similar articles
-
Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.Br J Dermatol. 2015 Oct;173(4):940-8. doi: 10.1111/bjd.13934. Epub 2015 Oct 1. Br J Dermatol. 2015. PMID: 26036329 Clinical Trial.
-
Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.J Dermatol. 2010 Feb;37(2):137-9. doi: 10.1111/j.1346-8138.2009.00773.x. J Dermatol. 2010. PMID: 20175847
-
Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.J Dermatolog Treat. 2016 Aug;27(4):359-63. doi: 10.3109/09546634.2015.1109029. Epub 2015 Nov 11. J Dermatolog Treat. 2016. PMID: 26471716
-
Onychomycosis in the elderly : drug treatment options.Drugs Aging. 2007;24(4):293-302. doi: 10.2165/00002512-200724040-00003. Drugs Aging. 2007. PMID: 17432924 Review.
-
Tinea Unguium: Diagnosis and Treatment in Practice.Mycopathologia. 2017 Feb;182(1-2):95-100. doi: 10.1007/s11046-016-0078-4. Epub 2016 Oct 27. Mycopathologia. 2017. PMID: 27787643 Review.
Cited by
-
Influence of gamma irradiation on rosin properties and its antimicrobial activity.Sci Rep. 2023 Mar 18;13(1):4500. doi: 10.1038/s41598-023-31372-7. Sci Rep. 2023. PMID: 36934117 Free PMC article.
-
Clinical Prevalence, Antibiogram Profiling and Gompertz Growth Kinetics of Resistant Staphylococcus epidermidis Treated with Nanoparticles of Rosin Extracted from Pinus roxburghii.Antibiotics (Basel). 2022 Sep 19;11(9):1270. doi: 10.3390/antibiotics11091270. Antibiotics (Basel). 2022. PMID: 36140049 Free PMC article.
-
Complementary and Alternative Therapies for Onychomycosis: A Systematic Review of the Clinical Evidence.Skin Appendage Disord. 2022 Jul;8(4):269-279. doi: 10.1159/000521703. Epub 2022 Feb 9. Skin Appendage Disord. 2022. PMID: 35983465 Free PMC article.
-
Mechanistic Insights of Formulation Approaches for the Treatment of Nail Infection: Conventional and Novel Drug Delivery Approaches.AAPS PharmSciTech. 2020 Jan 14;21(2):67. doi: 10.1208/s12249-019-1591-9. AAPS PharmSciTech. 2020. PMID: 31938980 Review.
-
Challenges and Opportunities in the Management of Onychomycosis.J Fungi (Basel). 2018 Jul 24;4(3):87. doi: 10.3390/jof4030087. J Fungi (Basel). 2018. PMID: 30042327 Free PMC article. Review.
References
-
- Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol. 2004;150:537–44. - PubMed
-
- Faergemann J, Anderson C, Hersle K, et al. Double blind, parallel group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. J Am Acad Dermatol. 1995;32:750–3. - PubMed
-
- Heikkilä H, Stubb S, Reitamo S. A study of 72 patients with contact allergy to tioconazole. Br J Dermatol. 1996;134:678–80. - PubMed
-
- Elewski B, Pollak R, Ashton S, Rich P, Schlessinger J, Tavakkol A. A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis. Br J Dermatol. 2012;166:389–98. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources